Laura Fenton
Concepts (358)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Magnetic Resonance Imaging | 23 | 2026 | 3926 | 1.090 |
Why?
| | Entorhinal Cortex | 1 | 2024 | 15 | 0.850 |
Why?
| | Brain Stem Neoplasms | 5 | 2015 | 86 | 0.740 |
Why?
| | Tomography, X-Ray Computed | 11 | 2014 | 2786 | 0.650 |
Why?
| | Scrotum | 2 | 2016 | 25 | 0.650 |
Why?
| | Brain | 7 | 2026 | 2991 | 0.630 |
Why?
| | Neuroimaging | 1 | 2022 | 307 | 0.610 |
Why?
| | Ganglioglioma | 2 | 2015 | 34 | 0.510 |
Why?
| | Esophagus | 3 | 2015 | 260 | 0.500 |
Why?
| | Wounds, Nonpenetrating | 3 | 2016 | 305 | 0.500 |
Why?
| | Cognitive Dysfunction | 1 | 2023 | 481 | 0.480 |
Why?
| | Diagnostic Techniques, Digestive System | 1 | 2015 | 12 | 0.460 |
Why?
| | Eosinophilic Esophagitis | 2 | 2020 | 333 | 0.450 |
Why?
| | Brain Diseases | 2 | 2019 | 159 | 0.440 |
Why?
| | Esophageal Stenosis | 1 | 2015 | 60 | 0.440 |
Why?
| | Osteitis | 1 | 2013 | 4 | 0.390 |
Why?
| | Infratentorial Neoplasms | 1 | 2014 | 69 | 0.390 |
Why?
| | Eosinophils | 1 | 2015 | 319 | 0.380 |
Why?
| | Child | 34 | 2024 | 22693 | 0.370 |
Why?
| | Ultrasonography | 3 | 2016 | 788 | 0.370 |
Why?
| | Positron-Emission Tomography | 2 | 2019 | 343 | 0.360 |
Why?
| | Proto-Oncogene Proteins B-raf | 1 | 2014 | 231 | 0.350 |
Why?
| | Prosthesis-Related Infections | 1 | 2013 | 100 | 0.350 |
Why?
| | Glioma | 2 | 2009 | 425 | 0.350 |
Why?
| | Gastritis | 1 | 2013 | 117 | 0.340 |
Why?
| | Child, Preschool | 24 | 2019 | 11913 | 0.340 |
Why?
| | Enteritis | 1 | 2013 | 105 | 0.340 |
Why?
| | Urea Cycle Disorders, Inborn | 1 | 2011 | 26 | 0.340 |
Why?
| | Radiography | 8 | 2016 | 861 | 0.330 |
Why?
| | Eosinophilia | 1 | 2013 | 224 | 0.320 |
Why?
| | Male | 44 | 2026 | 73396 | 0.310 |
Why?
| | Radiation Injuries | 2 | 2019 | 149 | 0.310 |
Why?
| | Infant | 21 | 2019 | 10114 | 0.300 |
Why?
| | Liver Neoplasms | 3 | 2008 | 776 | 0.300 |
Why?
| | Colitis | 1 | 2013 | 283 | 0.300 |
Why?
| | Diagnosis, Differential | 9 | 2024 | 1503 | 0.300 |
Why?
| | Spinal Fusion | 1 | 2013 | 265 | 0.300 |
Why?
| | Female | 47 | 2026 | 79499 | 0.280 |
Why?
| | Humans | 62 | 2026 | 146342 | 0.280 |
Why?
| | Nervous System Diseases | 1 | 2011 | 288 | 0.270 |
Why?
| | Aging | 3 | 2026 | 1996 | 0.270 |
Why?
| | Pamphlets | 1 | 2007 | 26 | 0.260 |
Why?
| | Adolescent | 25 | 2024 | 22557 | 0.250 |
Why?
| | Sensitivity and Specificity | 4 | 2013 | 1998 | 0.250 |
Why?
| | Astrocytoma | 2 | 2007 | 128 | 0.250 |
Why?
| | Mutation | 3 | 2014 | 4093 | 0.240 |
Why?
| | Deglutition Disorders | 2 | 2020 | 159 | 0.240 |
Why?
| | Decision Making | 2 | 2024 | 993 | 0.230 |
Why?
| | Radiation Dosage | 1 | 2007 | 193 | 0.230 |
Why?
| | Reproducibility of Results | 6 | 2015 | 3416 | 0.230 |
Why?
| | Infant, Newborn | 16 | 2019 | 6460 | 0.220 |
Why?
| | Healthy Aging | 1 | 2026 | 44 | 0.220 |
Why?
| | Stroke | 3 | 2022 | 1287 | 0.220 |
Why?
| | Vertebral Artery Dissection | 2 | 2022 | 30 | 0.210 |
Why?
| | Brain Neoplasms | 3 | 2012 | 1325 | 0.210 |
Why?
| | Carcinoma, Hepatocellular | 1 | 2008 | 370 | 0.200 |
Why?
| | Ascorbic Acid Deficiency | 1 | 2024 | 10 | 0.200 |
Why?
| | Scurvy | 1 | 2024 | 18 | 0.200 |
Why?
| | Venous Thrombosis | 2 | 2016 | 199 | 0.190 |
Why?
| | Retrospective Studies | 14 | 2024 | 17438 | 0.190 |
Why?
| | Tomography, Emission-Computed | 1 | 2003 | 71 | 0.190 |
Why?
| | Testicular Hydrocele | 1 | 2002 | 3 | 0.180 |
Why?
| | Encephalocele | 1 | 2022 | 13 | 0.180 |
Why?
| | Cerebral Cortex | 2 | 2019 | 485 | 0.180 |
Why?
| | Brain Stem | 1 | 2003 | 101 | 0.180 |
Why?
| | Neuroblastoma | 2 | 2010 | 177 | 0.180 |
Why?
| | Teratoma | 1 | 2003 | 121 | 0.180 |
Why?
| | Rhabdoid Tumor | 1 | 2003 | 99 | 0.180 |
Why?
| | White Matter | 2 | 2026 | 169 | 0.170 |
Why?
| | Neurofibroma, Plexiform | 1 | 2001 | 12 | 0.170 |
Why?
| | Independent Living | 1 | 2023 | 114 | 0.170 |
Why?
| | Diagnostic Errors | 1 | 2003 | 178 | 0.170 |
Why?
| | Retroperitoneal Neoplasms | 1 | 2001 | 28 | 0.170 |
Why?
| | Mesentery | 1 | 2001 | 44 | 0.170 |
Why?
| | Abdomen | 1 | 2002 | 142 | 0.170 |
Why?
| | Intracranial Aneurysm | 1 | 2022 | 105 | 0.160 |
Why?
| | Parietal Bone | 1 | 2000 | 9 | 0.160 |
Why?
| | Child Abuse | 2 | 2012 | 545 | 0.160 |
Why?
| | Connective Tissue | 1 | 2000 | 39 | 0.160 |
Why?
| | Skull Fractures | 1 | 2000 | 36 | 0.160 |
Why?
| | Peritoneal Neoplasms | 1 | 2001 | 103 | 0.160 |
Why?
| | Pneumatosis Cystoides Intestinalis | 1 | 2000 | 21 | 0.160 |
Why?
| | Educational Status | 1 | 2023 | 466 | 0.160 |
Why?
| | Vitelline Duct | 1 | 2000 | 1 | 0.160 |
Why?
| | Radiotherapy | 2 | 2019 | 209 | 0.150 |
Why?
| | Intracranial Hemorrhages | 1 | 2000 | 106 | 0.150 |
Why?
| | Intestinal Obstruction | 1 | 2000 | 54 | 0.150 |
Why?
| | Cognition | 2 | 2026 | 1292 | 0.150 |
Why?
| | Prognosis | 5 | 2014 | 4351 | 0.140 |
Why?
| | Intestine, Small | 1 | 2000 | 160 | 0.140 |
Why?
| | Corpus Callosum | 1 | 2019 | 76 | 0.140 |
Why?
| | Bevacizumab | 1 | 2019 | 169 | 0.140 |
Why?
| | Hyperglycinemia, Nonketotic | 1 | 2019 | 56 | 0.140 |
Why?
| | Health Knowledge, Attitudes, Practice | 1 | 2007 | 1408 | 0.140 |
Why?
| | Parents | 1 | 2007 | 1394 | 0.140 |
Why?
| | Esophagoscopy | 2 | 2020 | 223 | 0.130 |
Why?
| | Disease-Free Survival | 2 | 2014 | 778 | 0.130 |
Why?
| | Radiopharmaceuticals | 2 | 2013 | 210 | 0.130 |
Why?
| | Fluorodeoxyglucose F18 | 2 | 2013 | 164 | 0.130 |
Why?
| | Fatty Liver | 2 | 2012 | 252 | 0.130 |
Why?
| | Fatal Outcome | 4 | 2016 | 302 | 0.130 |
Why?
| | tau Proteins | 1 | 2019 | 111 | 0.130 |
Why?
| | Angiogenesis Inhibitors | 1 | 2019 | 239 | 0.130 |
Why?
| | Magnetic Resonance Angiography | 1 | 2019 | 249 | 0.130 |
Why?
| | Smith-Magenis Syndrome | 1 | 2017 | 2 | 0.130 |
Why?
| | Aged | 5 | 2026 | 26432 | 0.130 |
Why?
| | Moyamoya Disease | 1 | 2017 | 20 | 0.130 |
Why?
| | Aged, 80 and over | 3 | 2026 | 8391 | 0.130 |
Why?
| | Central Nervous System Neoplasms | 1 | 2019 | 177 | 0.120 |
Why?
| | Ornithine Carbamoyltransferase Deficiency Disease | 1 | 2016 | 7 | 0.120 |
Why?
| | Hyperammonemia | 1 | 2016 | 17 | 0.120 |
Why?
| | Bronchopulmonary Sequestration | 1 | 1996 | 9 | 0.120 |
Why?
| | Antineoplastic Combined Chemotherapy Protocols | 2 | 2003 | 1998 | 0.120 |
Why?
| | Multimodal Imaging | 2 | 2019 | 137 | 0.120 |
Why?
| | Leigh Disease | 2 | 2013 | 22 | 0.120 |
Why?
| | Stomach | 1 | 1996 | 106 | 0.120 |
Why?
| | Treatment Outcome | 8 | 2014 | 11821 | 0.120 |
Why?
| | Young Adult | 6 | 2015 | 14330 | 0.120 |
Why?
| | Intracranial Thrombosis | 1 | 2016 | 19 | 0.120 |
Why?
| | Brain Infarction | 1 | 2016 | 23 | 0.120 |
Why?
| | Cerebral Veins | 1 | 2016 | 16 | 0.120 |
Why?
| | Vascular Malformations | 1 | 2016 | 53 | 0.120 |
Why?
| | Supratentorial Neoplasms | 1 | 2015 | 18 | 0.110 |
Why?
| | Delivery of Health Care | 1 | 2023 | 947 | 0.110 |
Why?
| | Cavernous Sinus Thrombosis | 1 | 2015 | 8 | 0.110 |
Why?
| | DNA Mutational Analysis | 2 | 2014 | 410 | 0.110 |
Why?
| | Contrast Media | 3 | 2019 | 493 | 0.110 |
Why?
| | Adrenal Gland Neoplasms | 1 | 1996 | 99 | 0.110 |
Why?
| | Cerebral Infarction | 1 | 2015 | 46 | 0.110 |
Why?
| | Portal Vein | 1 | 2016 | 123 | 0.110 |
Why?
| | Neurosurgical Procedures | 1 | 2017 | 209 | 0.110 |
Why?
| | Fibrin Fibrinogen Degradation Products | 2 | 2012 | 92 | 0.110 |
Why?
| | Abdominal Pain | 2 | 2011 | 149 | 0.110 |
Why?
| | Temporal Lobe | 1 | 2015 | 112 | 0.110 |
Why?
| | Lymphangiectasis | 1 | 2014 | 4 | 0.110 |
Why?
| | Lymphangiectasis, Intestinal | 1 | 2014 | 6 | 0.110 |
Why?
| | Carotid Stenosis | 1 | 2015 | 103 | 0.100 |
Why?
| | Spasm | 1 | 2013 | 21 | 0.100 |
Why?
| | Exercise | 1 | 2026 | 2213 | 0.100 |
Why?
| | Metal Metabolism, Inborn Errors | 1 | 2012 | 6 | 0.090 |
Why?
| | Cerebral Arterial Diseases | 1 | 2012 | 50 | 0.090 |
Why?
| | Neuroectodermal Tumors, Primitive | 1 | 2012 | 10 | 0.090 |
Why?
| | Pons | 1 | 2012 | 33 | 0.090 |
Why?
| | Alzheimer Disease | 1 | 2019 | 641 | 0.090 |
Why?
| | DNA, Mitochondrial | 1 | 2013 | 212 | 0.090 |
Why?
| | Accidents | 1 | 2012 | 43 | 0.090 |
Why?
| | Craniotomy | 1 | 2012 | 83 | 0.090 |
Why?
| | Athletic Injuries | 2 | 2016 | 575 | 0.090 |
Why?
| | Splenomegaly | 1 | 2011 | 15 | 0.080 |
Why?
| | Diffusion Magnetic Resonance Imaging | 1 | 2012 | 158 | 0.080 |
Why?
| | Hemoglobin SC Disease | 1 | 2011 | 14 | 0.080 |
Why?
| | Necrosis | 3 | 2019 | 243 | 0.080 |
Why?
| | Decompression, Surgical | 1 | 2012 | 115 | 0.080 |
Why?
| | Succinate-CoA Ligases | 1 | 2010 | 4 | 0.080 |
Why?
| | Brain Diseases, Metabolic | 1 | 2010 | 8 | 0.080 |
Why?
| | Blood Coagulation Disorders | 1 | 2012 | 190 | 0.080 |
Why?
| | Liver Diseases | 2 | 2010 | 304 | 0.080 |
Why?
| | Magnetic Resonance Spectroscopy | 1 | 2012 | 627 | 0.080 |
Why?
| | Scoliosis | 1 | 2013 | 231 | 0.080 |
Why?
| | Neoplasms, Radiation-Induced | 1 | 2010 | 100 | 0.080 |
Why?
| | Fibrinolytic Agents | 1 | 2012 | 303 | 0.080 |
Why?
| | Anticoagulants | 1 | 2015 | 746 | 0.080 |
Why?
| | Recurrence | 3 | 2022 | 1133 | 0.080 |
Why?
| | Mitochondrial Diseases | 1 | 2010 | 94 | 0.070 |
Why?
| | Incidental Findings | 1 | 2010 | 81 | 0.070 |
Why?
| | Thrombophilia | 1 | 2009 | 89 | 0.070 |
Why?
| | Lymphoproliferative Disorders | 1 | 2009 | 59 | 0.070 |
Why?
| | Optic Neuritis | 1 | 2009 | 44 | 0.070 |
Why?
| | Facial Bones | 1 | 2009 | 28 | 0.070 |
Why?
| | Facial Injuries | 1 | 2009 | 25 | 0.070 |
Why?
| | Autopsy | 2 | 2016 | 96 | 0.070 |
Why?
| | Diabetes, Gestational | 1 | 2012 | 307 | 0.070 |
Why?
| | Liver | 2 | 2016 | 1864 | 0.070 |
Why?
| | Cerebellar Neoplasms | 1 | 2010 | 169 | 0.070 |
Why?
| | Chromosomes, Human, Y | 1 | 2008 | 36 | 0.070 |
Why?
| | Prenatal Diagnosis | 1 | 2010 | 190 | 0.070 |
Why?
| | Biopsy | 2 | 2010 | 1075 | 0.070 |
Why?
| | Medulloblastoma | 1 | 2010 | 208 | 0.070 |
Why?
| | Epstein-Barr Virus Infections | 1 | 2009 | 102 | 0.070 |
Why?
| | Chromosomes, Human, X | 1 | 2008 | 76 | 0.070 |
Why?
| | Meningomyelocele | 1 | 2008 | 63 | 0.070 |
Why?
| | Sex Chromosome Aberrations | 1 | 2008 | 67 | 0.070 |
Why?
| | Craniopharyngioma | 1 | 2009 | 77 | 0.070 |
Why?
| | Aneuploidy | 1 | 2008 | 88 | 0.070 |
Why?
| | Lung Diseases | 1 | 2014 | 787 | 0.070 |
Why?
| | Ultrasonography, Doppler | 1 | 2008 | 122 | 0.060 |
Why?
| | Middle Aged | 4 | 2024 | 36619 | 0.060 |
Why?
| | Glioblastoma | 1 | 2010 | 350 | 0.060 |
Why?
| | Obesity | 2 | 2012 | 3131 | 0.060 |
Why?
| | Glucose Tolerance Test | 1 | 2008 | 360 | 0.060 |
Why?
| | Brain Injuries | 1 | 2012 | 499 | 0.060 |
Why?
| | Abnormalities, Multiple | 1 | 2008 | 195 | 0.060 |
Why?
| | Vascular Diseases | 1 | 2009 | 252 | 0.060 |
Why?
| | Carotid Artery Thrombosis | 1 | 2005 | 6 | 0.060 |
Why?
| | Brain Ischemia | 1 | 2009 | 362 | 0.060 |
Why?
| | Mucormycosis | 1 | 2005 | 18 | 0.060 |
Why?
| | Osteoporosis | 1 | 2008 | 240 | 0.060 |
Why?
| | Adult | 8 | 2019 | 41087 | 0.060 |
Why?
| | Developmental Disabilities | 1 | 2008 | 281 | 0.050 |
Why?
| | Actigraphy | 1 | 2026 | 148 | 0.050 |
Why?
| | Bone Density | 1 | 2008 | 494 | 0.050 |
Why?
| | Metabolic Syndrome | 1 | 2008 | 364 | 0.050 |
Why?
| | Meninges | 1 | 2024 | 54 | 0.050 |
Why?
| | Meningeal Neoplasms | 1 | 2024 | 95 | 0.050 |
Why?
| | Meningitis | 1 | 2024 | 80 | 0.050 |
Why?
| | Follow-Up Studies | 4 | 2016 | 5439 | 0.050 |
Why?
| | Carboplatin | 1 | 2003 | 168 | 0.050 |
Why?
| | Sinusitis | 1 | 2005 | 221 | 0.050 |
Why?
| | Vincristine | 1 | 2003 | 148 | 0.050 |
Why?
| | Feasibility Studies | 2 | 2019 | 1135 | 0.050 |
Why?
| | Hernia, Hiatal | 1 | 2003 | 38 | 0.050 |
Why?
| | Risk Factors | 5 | 2012 | 10921 | 0.050 |
Why?
| | Ascorbic Acid | 1 | 2024 | 183 | 0.050 |
Why?
| | Liver Transplantation | 1 | 2009 | 751 | 0.050 |
Why?
| | Vertebral Artery | 1 | 2022 | 25 | 0.040 |
Why?
| | Hemangioendothelioma | 1 | 2002 | 13 | 0.040 |
Why?
| | Pilot Projects | 2 | 2019 | 1888 | 0.040 |
Why?
| | Pancreatic Neoplasms | 1 | 2010 | 944 | 0.040 |
Why?
| | Colorado | 4 | 2015 | 4595 | 0.040 |
Why?
| | Ultrasonography, Prenatal | 2 | 2010 | 291 | 0.040 |
Why?
| | Spinal Cord Neoplasms | 1 | 2001 | 40 | 0.040 |
Why?
| | Executive Function | 1 | 2026 | 463 | 0.040 |
Why?
| | Vitamin K Deficiency | 1 | 2000 | 9 | 0.040 |
Why?
| | Neurofibromatosis 1 | 1 | 2001 | 59 | 0.040 |
Why?
| | Disseminated Intravascular Coagulation | 1 | 2000 | 34 | 0.040 |
Why?
| | Dilatation | 1 | 2020 | 73 | 0.040 |
Why?
| | Diseases in Twins | 1 | 2000 | 115 | 0.040 |
Why?
| | Cross-Sectional Studies | 4 | 2019 | 5899 | 0.040 |
Why?
| | Enema | 1 | 2000 | 46 | 0.040 |
Why?
| | Herpes Simplex | 1 | 2000 | 103 | 0.040 |
Why?
| | Carotid Artery Diseases | 1 | 2019 | 70 | 0.040 |
Why?
| | Neck | 1 | 2019 | 107 | 0.040 |
Why?
| | Ependymoma | 1 | 2001 | 177 | 0.040 |
Why?
| | Carbolines | 1 | 2019 | 35 | 0.040 |
Why?
| | Mental Disorders | 1 | 2008 | 1148 | 0.040 |
Why?
| | Spectrum Analysis | 1 | 2019 | 85 | 0.040 |
Why?
| | Atrophy | 1 | 2019 | 199 | 0.030 |
Why?
| | Biomarkers | 1 | 2009 | 4340 | 0.030 |
Why?
| | Thiazoles | 1 | 2019 | 139 | 0.030 |
Why?
| | Predictive Value of Tests | 1 | 2003 | 2113 | 0.030 |
Why?
| | Inflammation | 1 | 2009 | 2919 | 0.030 |
Why?
| | Aniline Compounds | 1 | 2019 | 120 | 0.030 |
Why?
| | Algorithms | 1 | 2026 | 1849 | 0.030 |
Why?
| | Organ Size | 1 | 2019 | 465 | 0.030 |
Why?
| | Cohort Studies | 3 | 2016 | 6077 | 0.030 |
Why?
| | Gastroepiploic Artery | 1 | 2017 | 4 | 0.030 |
Why?
| | Pregnancy | 5 | 2012 | 7230 | 0.030 |
Why?
| | Cerebral Revascularization | 1 | 2017 | 22 | 0.030 |
Why?
| | Dexamethasone | 1 | 2019 | 368 | 0.030 |
Why?
| | Ultrasonography, Doppler, Color | 1 | 2016 | 37 | 0.030 |
Why?
| | Cerebral Angiography | 1 | 2017 | 121 | 0.030 |
Why?
| | Phenotype | 2 | 2019 | 3206 | 0.030 |
Why?
| | Acidosis, Lactic | 1 | 2016 | 46 | 0.030 |
Why?
| | Imaging, Three-Dimensional | 1 | 2019 | 582 | 0.030 |
Why?
| | Congenital Abnormalities | 1 | 1996 | 108 | 0.030 |
Why?
| | Florida | 1 | 2015 | 117 | 0.030 |
Why?
| | Intellectual Disability | 1 | 2017 | 183 | 0.030 |
Why?
| | Glucocorticoids | 1 | 2019 | 536 | 0.030 |
Why?
| | Endpoint Determination | 1 | 2015 | 84 | 0.030 |
Why?
| | Single-Blind Method | 1 | 2015 | 313 | 0.030 |
Why?
| | Observer Variation | 1 | 2015 | 356 | 0.030 |
Why?
| | Combined Modality Therapy | 2 | 2009 | 1271 | 0.030 |
Why?
| | Quality Assurance, Health Care | 1 | 2015 | 349 | 0.020 |
Why?
| | Molybdoferredoxin | 1 | 2012 | 13 | 0.020 |
Why?
| | Diagnostic Imaging | 1 | 2015 | 340 | 0.020 |
Why?
| | Hemorrhage | 2 | 2015 | 825 | 0.020 |
Why?
| | Erythroblastosis, Fetal | 1 | 1972 | 5 | 0.020 |
Why?
| | Pedigree | 1 | 2013 | 512 | 0.020 |
Why?
| | Persistent Vegetative State | 1 | 2012 | 5 | 0.020 |
Why?
| | Time Factors | 2 | 2015 | 7109 | 0.020 |
Why?
| | Splenectomy | 1 | 2011 | 61 | 0.020 |
Why?
| | Case-Control Studies | 1 | 2019 | 3647 | 0.020 |
Why?
| | Glasgow Coma Scale | 1 | 2012 | 211 | 0.020 |
Why?
| | Longitudinal Studies | 1 | 2019 | 3017 | 0.020 |
Why?
| | Karyotyping | 1 | 2010 | 106 | 0.020 |
Why?
| | Accidents, Traffic | 1 | 2012 | 193 | 0.020 |
Why?
| | Anemia | 1 | 1972 | 190 | 0.020 |
Why?
| | Biopsy, Needle | 1 | 2010 | 183 | 0.020 |
Why?
| | Optic Nerve | 1 | 2009 | 65 | 0.020 |
Why?
| | Factor VIII | 1 | 2009 | 107 | 0.020 |
Why?
| | Rare Diseases | 1 | 2010 | 117 | 0.020 |
Why?
| | Research Design | 1 | 2015 | 1143 | 0.020 |
Why?
| | Fractures, Spontaneous | 1 | 2008 | 15 | 0.020 |
Why?
| | Wheelchairs | 1 | 2008 | 16 | 0.020 |
Why?
| | Body Composition | 1 | 2012 | 689 | 0.020 |
Why?
| | Diabetes Mellitus, Type 1 | 1 | 2005 | 3930 | 0.020 |
Why?
| | Oligonucleotide Array Sequence Analysis | 1 | 2010 | 752 | 0.020 |
Why?
| | Calcium, Dietary | 1 | 2008 | 52 | 0.020 |
Why?
| | Cell Transformation, Neoplastic | 1 | 2010 | 314 | 0.020 |
Why?
| | Neurologic Examination | 1 | 2008 | 129 | 0.020 |
Why?
| | Mobility Limitation | 1 | 2008 | 68 | 0.020 |
Why?
| | Fetal Diseases | 1 | 2010 | 192 | 0.020 |
Why?
| | Adiposity | 1 | 2012 | 533 | 0.020 |
Why?
| | Cesarean Section | 1 | 2010 | 230 | 0.020 |
Why?
| | Age of Onset | 1 | 2009 | 558 | 0.020 |
Why?
| | Gestational Age | 2 | 2010 | 990 | 0.020 |
Why?
| | Prenatal Care | 1 | 2010 | 310 | 0.020 |
Why?
| | Absorptiometry, Photon | 1 | 2008 | 278 | 0.020 |
Why?
| | Recovery of Function | 1 | 2012 | 725 | 0.020 |
Why?
| | C-Reactive Protein | 1 | 2009 | 429 | 0.020 |
Why?
| | Bleomycin | 1 | 2009 | 255 | 0.020 |
Why?
| | Syndrome | 1 | 2008 | 380 | 0.020 |
Why?
| | Cholesterol, HDL | 1 | 2008 | 201 | 0.020 |
Why?
| | Pancreatectomy | 1 | 2010 | 289 | 0.020 |
Why?
| | Base Sequence | 1 | 2010 | 2123 | 0.020 |
Why?
| | Amino Acid Sequence | 1 | 2010 | 2092 | 0.010 |
Why?
| | Mucor | 1 | 2005 | 7 | 0.010 |
Why?
| | Telencephalon | 1 | 2005 | 16 | 0.010 |
Why?
| | Molecular Sequence Data | 1 | 2010 | 2838 | 0.010 |
Why?
| | Cavernous Sinus | 1 | 2005 | 16 | 0.010 |
Why?
| | Immunohistochemistry | 1 | 2010 | 1712 | 0.010 |
Why?
| | Survival Rate | 1 | 2010 | 2092 | 0.010 |
Why?
| | Triglycerides | 1 | 2008 | 527 | 0.010 |
Why?
| | Orbit | 1 | 2005 | 67 | 0.010 |
Why?
| | Paranasal Sinuses | 1 | 2005 | 77 | 0.010 |
Why?
| | Gene Expression Regulation, Neoplastic | 1 | 2010 | 1432 | 0.010 |
Why?
| | Incidence | 1 | 2009 | 2936 | 0.010 |
Why?
| | Prospective Studies | 2 | 2009 | 8123 | 0.010 |
Why?
| | Cleft Lip | 1 | 2003 | 73 | 0.010 |
Why?
| | Cleft Palate | 1 | 2003 | 91 | 0.010 |
Why?
| | United States | 1 | 2019 | 16136 | 0.010 |
Why?
| | Estrogen Receptor Modulators | 1 | 2001 | 14 | 0.010 |
Why?
| | Laminectomy | 1 | 2001 | 30 | 0.010 |
Why?
| | Blood Pressure | 1 | 2008 | 1765 | 0.010 |
Why?
| | Etoposide | 1 | 2001 | 169 | 0.010 |
Why?
| | Radiotherapy, Adjuvant | 1 | 2001 | 222 | 0.010 |
Why?
| | Tamoxifen | 1 | 2001 | 193 | 0.010 |
Why?
| | Risk Assessment | 1 | 2010 | 3712 | 0.010 |
Why?
| | Chemotherapy, Adjuvant | 1 | 2001 | 429 | 0.010 |
Why?
| | Low Back Pain | 1 | 2001 | 109 | 0.010 |
Why?
| | Body Mass Index | 1 | 2008 | 2458 | 0.010 |
Why?
| | Evaluation Studies as Topic | 1 | 1999 | 161 | 0.010 |
Why?
| | Blood Glucose | 1 | 2008 | 2360 | 0.010 |
Why?
| | Appendicitis | 1 | 1999 | 151 | 0.010 |
Why?
| | Acute Disease | 1 | 1999 | 1038 | 0.010 |
Why?
| | Parathyroid Glands | 1 | 1975 | 11 | 0.010 |
Why?
| | Neoplasm Recurrence, Local | 1 | 2001 | 1160 | 0.010 |
Why?
| | Infant, Newborn, Diseases | 1 | 1975 | 113 | 0.010 |
Why?
| | Pregnancy in Diabetics | 1 | 1975 | 123 | 0.010 |
Why?
| | Kidney Cortex Necrosis | 1 | 1972 | 1 | 0.010 |
Why?
| | Splenic Rupture | 1 | 1972 | 5 | 0.010 |
Why?
| | Exchange Transfusion, Whole Blood | 1 | 1972 | 18 | 0.010 |
Why?
| | Hemoperitoneum | 1 | 1972 | 10 | 0.010 |
Why?
| | Pulmonary Edema | 1 | 1972 | 105 | 0.010 |
Why?
| | Brain Edema | 1 | 1972 | 63 | 0.010 |
Why?
| | Pancreatic Diseases | 1 | 1972 | 64 | 0.010 |
Why?
| | Cerebral Hemorrhage | 1 | 1972 | 125 | 0.010 |
Why?
| | Spleen | 1 | 1972 | 503 | 0.000 |
Why?
| | Pulmonary Alveoli | 1 | 1972 | 385 | 0.000 |
Why?
| | Emergency Service, Hospital | 1 | 1999 | 2363 | 0.000 |
Why?
| | Hypocalcemia | 1 | 1975 | 40 | 0.000 |
Why?
| | Phosphorus | 1 | 1975 | 89 | 0.000 |
Why?
| | Umbilical Cord | 1 | 1975 | 92 | 0.000 |
Why?
| | Blood | 1 | 1975 | 107 | 0.000 |
Why?
| | Magnesium | 1 | 1975 | 155 | 0.000 |
Why?
| | Parathyroid Hormone | 1 | 1975 | 118 | 0.000 |
Why?
| | Phosphates | 1 | 1975 | 175 | 0.000 |
Why?
| | Calcium | 1 | 1975 | 1181 | 0.000 |
Why?
|
|
Fenton's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|